{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:51:29Z","timestamp":1784029889983,"version":"3.55.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Although antiseizure medications play a crucial role in the management of epilepsy, their benefit can be compromised due to drug-related problems. Drug therapy problems can lead to poor seizure control, reduced quality of life, and increased morbidity and mortality in patients with epilepsy. However, in our setting, there is limited knowledge about drug therapy problems and the factors that contribute to them.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objective<\/jats:title>\n<jats:p>The aim of this study was to investigate the prevalence and contributing factors of drug-therapy problems among patients with epilepsy.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methodology<\/jats:title>\n<jats:p>A hospital-based prospective observational study was conducted at the neurologic clinic of Ayder Comprehensive Specialized Hospital, located in the Tigray region of Northern Ethiopia. The study included adult patients diagnosed with epilepsy who had been taking at least one antiseizure medication for a minimum of six months. Data were collected by conducting patient interviews and expert reviews of medical and medication records. Prior to data review and interviews, each patient provided written informed consent. Drug therapy problems were identified and classified using Cipolle\u2019s method, followed by a consensus review conducted with a panel of experts. Statistical analysis was performed using a statistical software package; SPSS version 22. Binary logistic regression analysis was conducted to determine the contributing factors of drug therapy problems. Statistical significance was determined at p&lt;0.05.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>A study conducted on 250 participants revealed that 55.2% of the patients experienced one or more drug therapy problems. Our analysis identified a total of 282 drug therapy problems, with a mean of 2\u00b10.52 drug therapy problems per patient. The most commonly observed drug therapy problems were dosage too low (30.0%), noncompliance (22%), adverse drug reaction (18%), and unnecessary drug therapy (16.4%). The commonly involved antiseizure medications in these drug therapy problems were phenytoin (22.8%), Valproic acid (20.8%), and Phenobarbital (18.4%). Furthermore, our findings revealed that combination therapy (AOR: 3.92, 95%CI: 1.19\u201312.97) and uncontrolled seizure (AOR: 108.37, 95%CI: 38.7\u2013303.6) exhibited significant associations with drug therapy problems.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Drug therapy problems were prevalent among patients with epilepsy. The use of combination therapy and the presence of uncontrolled seizures were identified as significant indicators of drug therapy problems. Therefore, more emphasis should be given to patients with multiple medications and uncontrolled seizures.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0299968","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T18:39:32Z","timestamp":1709836772000},"page":"e0299968","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Drug therapy problems and contributing factors among patients with epilepsy"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6943-753X","authenticated-orcid":true,"given":"Yirga Legesse","family":"Niriayo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfay","family":"Gebregziabher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebre Teklemariam","family":"Demoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigusse","family":"Tesfay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kidu","family":"Gidey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"issue":"7","key":"pone.0299968.ref001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/neuroindia.NI_1027_16","article-title":"Evidence-based guidelines for the management of epilepsy","volume":"65","author":"SP Singh","year":"2017","journal-title":"Neurology India"},{"key":"pone.0299968.ref002","first-page":"467","article-title":"Medical management of epileptic seizures: challenges and solutions.","volume":"12","author":"AK Sarma","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"11","key":"pone.0299968.ref003","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1007\/s00415-013-7058-0","article-title":"Treatment of epilepsy in daily clinical practice: have outcomes improved over the past 10 years?","volume":"260","author":"M Wassenaar","year":"2013","journal-title":"Journal of neurology"},{"issue":"1","key":"pone.0299968.ref004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yebeh.2009.02.030","article-title":"Drug treatment of epilepsy: options and limitations","volume":"15","author":"D. Schmidt","year":"2009","journal-title":"Epilepsy & behavior."},{"key":"pone.0299968.ref005","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.seizure.2016.09.002","article-title":"Long-term outcome of medically treated epilepsy.","volume":"44","author":"M Sillanp\u00e4\u00e4","year":"2017","journal-title":"Seizure"},{"issue":"1","key":"pone.0299968.ref006","doi-asserted-by":"crossref","first-page":"17354","DOI":"10.1038\/s41598-018-35906-2","article-title":"Treatment outcome and associated factors among patients with epilepsy.","volume":"8","author":"YL Niriayo","year":"2018","journal-title":"Scientific Reports"},{"issue":"7605","key":"pone.0299968.ref007","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/bmj.39065.460208.80","article-title":"Treatment of epilepsy in developing countries","volume":"334","author":"E. Perucca","year":"2007","journal-title":"BMJ (Clinical research ed)."},{"key":"pone.0299968.ref008","doi-asserted-by":"crossref","first-page":"2806341","DOI":"10.1155\/2019\/2806341","article-title":"Medication Belief and Adherence among Patients with Epilepsy.","volume":"2019","author":"YL Niriayo","year":"2019","journal-title":"Behav Neurol."},{"issue":"9","key":"pone.0299968.ref009","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/j.1528-1167.2008.01693.x","article-title":"The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies","volume":"49","author":"CK Mbuba","year":"2008","journal-title":"Epilepsia"},{"issue":"3","key":"pone.0299968.ref010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.yebeh.2010.12.045","article-title":"Multicultural challenges in epilepsy.","volume":"20","author":"E Bartolini","year":"2011","journal-title":"Epilepsy & behavior: E&B."},{"issue":"2","key":"pone.0299968.ref011","first-page":"186","article-title":"Epilepsy treatment in sub-Saharan Africa: closing the gap.","volume":"12","author":"JH Chin","year":"2012","journal-title":"African health sciences."},{"key":"pone.0299968.ref012","doi-asserted-by":"crossref","first-page":"1086622","DOI":"10.3389\/fneur.2023.1086622","article-title":"Ethiopians\u2019 knowledge of and attitudes toward epilepsy: A systematic review and meta-analysis","volume":"14","author":"BZ Woldegeorgis","year":"2023","journal-title":"Frontiers in Neurology"},{"key":"pone.0299968.ref013","doi-asserted-by":"crossref","first-page":"107872","DOI":"10.1016\/j.yebeh.2021.107872","article-title":"Stigma and associated factors among people with epilepsy in Ethiopia: A systematic review and meta-analysis.","volume":"117","author":"RO Fite","year":"2021","journal-title":"Epilepsy & behavior: E&B."},{"key":"pone.0299968.ref014","doi-asserted-by":"crossref","first-page":"107791","DOI":"10.1016\/j.yebeh.2021.107791","article-title":"Climate change and epilepsy: Insights from clinical and basic science studies.","volume":"116","author":"MI Gulcebi","year":"2021","journal-title":"Epilepsy & behavior: E&B."},{"key":"pone.0299968.ref015","author":"LM Strand","year":"2012","journal-title":"Pharmaceutical care practice: McGraw-Hill New York"},{"issue":"4","key":"pone.0299968.ref016","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1060028014568008","article-title":"Development of an aggregated system for classifying causes of drug-related problems","volume":"49","author":"BJ Basger","year":"2015","journal-title":"Annals of Pharmacotherapy"},{"issue":"Suppl 1","key":"pone.0299968.ref017","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.4103\/0976-500X.120957","article-title":"Clinical and economic burden of adverse drug reactions","volume":"4","author":"J Sultana","year":"2013","journal-title":"Journal of pharmacology & pharmacotherapeutics"},{"issue":"1","key":"pone.0299968.ref018","first-page":"59","article-title":"[Economic impact of the resolution of drug related problems in an Emergency Department].","volume":"37","author":"M Ucha-Samart\u00edn","year":"2013","journal-title":"Farmacia hospitalaria: organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria."},{"issue":"10","key":"pone.0299968.ref019","doi-asserted-by":"crossref","first-page":"e0206120","DOI":"10.1371\/journal.pone.0206120","article-title":"Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia.","volume":"13","author":"YL Niriayo","year":"2018","journal-title":"PLoS One."},{"issue":"1","key":"pone.0299968.ref020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society.","volume":"16","author":"T Glauser","year":"2016","journal-title":"Epilepsy currents."},{"key":"pone.0299968.ref021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vhri.2014.07.009","article-title":"Antiepileptic drugs and quality of life in patients with epilepsy: a tertiary care hospital-based study.","volume":"6","author":"J George","year":"2015","journal-title":"Value in health regional issues."},{"key":"pone.0299968.ref022","unstructured":"Organization WH. Epilepsy in the WHO African region: bridging the gap. Belhocine, M, de Boer, H, and Mandlhate, C Geneva. 2004."},{"issue":"9","key":"pone.0299968.ref023","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","article-title":"Adverse effects of antiepileptic drugs","volume":"11","author":"P Perucca","year":"2012","journal-title":"The Lancet Neurology"},{"issue":"11","key":"pone.0299968.ref024","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1468-1331.2009.02713.x","article-title":"Adjustment of treatment increases quality of life in patients with epilepsy: a randomized controlled pragmatic trial","volume":"16","author":"S Uijl","year":"2009","journal-title":"European journal of neurology"},{"issue":"3","key":"pone.0299968.ref025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1684\/epd.2013.0588","article-title":"Adherence to treatment and influencing factors in a sample of Chinese epilepsy patients.","volume":"15","author":"J Liu","year":"2013","journal-title":"Epileptic disorders."},{"key":"pone.0299968.ref026","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2471\/BLT.09.064147","article-title":"Global disparities in the epilepsy treatment gap: a systematic review","volume":"88","author":"A-C Meyer","year":"2010","journal-title":"Bulletin of the World Health Organization"},{"issue":"20","key":"pone.0299968.ref027","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1212\/01.wnl.0000319693.10338.b9","article-title":"Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study","volume":"71","author":"E Faught","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"pone.0299968.ref028","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.yebeh.2008.03.009","article-title":"Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians.","volume":"13","author":"CA Hovinga","year":"2008","journal-title":"Epilepsy Behav."},{"issue":"1","key":"pone.0299968.ref029","doi-asserted-by":"crossref","first-page":"e0227359","DOI":"10.1371\/journal.pone.0227359","article-title":"Drug therapy problems and treatment satisfaction among ambulatory patients with epilepsy in a specialized hospital in Ethiopia.","volume":"15","author":"BB Nasir","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"pone.0299968.ref030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jppr.1001","article-title":"Assessing the pharmaceutical care issues of antiepileptic drug therapy in hospitalised epileptic patients","volume":"44","author":"MM Manan","year":"2014","journal-title":"Journal of Pharmacy Practice and Research"},{"issue":"12","key":"pone.0299968.ref031","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/epi.13217","article-title":"Developing clinical practice guidelines for epilepsy: A report from the ILAE Epilepsy Guidelines Working Group","volume":"56","author":"KM Sauro","year":"2015","journal-title":"Epilepsia"},{"issue":"1","key":"pone.0299968.ref032","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13690-020-00405-2","article-title":"A systematic review and meta-analysis of anti-epileptic medication non-adherence among people with epilepsy in Ethiopia.","volume":"78","author":"Z Belayneh","year":"2020","journal-title":"Archives of Public Health"},{"issue":"3","key":"pone.0299968.ref033","first-page":"267","article-title":"The problem of epilepsy and its care in rural Ethiopia.","volume":"46","author":"Y Mamo","year":"2008","journal-title":"Ethiop Med J"},{"issue":"3","key":"pone.0299968.ref034","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/epi4.12792","article-title":"Availability, price, and affordability of antiseizure medicines in Addis Ababa, Ethiopia.","volume":"8","author":"FH Hailemariam","year":"2023","journal-title":"Epilepsia Open"},{"issue":"8","key":"pone.0299968.ref035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4103\/1947-2714.139288","article-title":"Knowledge, attitude, and practice of epileptic patients towards their illness and treatment in Jimma University specialized hospital, Southwest Ethiopia.","volume":"6","author":"GM Kassie","year":"2014","journal-title":"North American journal of medical sciences"},{"key":"pone.0299968.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-018-3190-y","article-title":"Implementing integrated services for people with epilepsy in primary care in Ethiopia: a qualitative study.","volume":"18","author":"R Catalao","year":"2018","journal-title":"BMC Health Services Research"},{"key":"pone.0299968.ref037","first-page":"344","article-title":"The treatment of epilepsy in developing countries: where do we go from here?","volume":"79","author":"RA Scott","year":"2001","journal-title":"Bulletin of the World Health Organization"},{"key":"pone.0299968.ref038","article-title":"Medication adherence: WHO cares?","author":"MT Brown","year":"2011","journal-title":"Mayo Clinic Proceedings"},{"issue":"3","key":"pone.0299968.ref039","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.yebeh.2011.04.011","article-title":"Self-reported medication adherence and treatment satisfaction in patients with epilepsy.","volume":"21","author":"WM Sweileh","year":"2011","journal-title":"Epilepsy & Behavior."},{"issue":"1","key":"pone.0299968.ref040","first-page":"25","article-title":"Factors associated with irrational drug use at a district hospital in Zambia: patient record-based observations","volume":"42","author":"V Lukali","year":"2015","journal-title":"Medical Journal of Zambia"},{"issue":"16","key":"pone.0299968.ref041","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1212\/WNL.0000000000001487","article-title":"Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"84","author":"A Krumholz","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"pone.0299968.ref042","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"T Glauser","year":"2006","journal-title":"Epilepsia"},{"issue":"507","key":"pone.0299968.ref043","first-page":"781","article-title":"The outcome of initiation of antiepileptic drug monotherapy in primary care: a UK database survey.","volume":"54","author":"CL Morgan","year":"2004","journal-title":"The British journal of general practice: the journal of the Royal College of General Practitioners"},{"issue":"1","key":"pone.0299968.ref044","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eplepsyres.2008.11.018","article-title":"Antiepileptic drug utilization in Taiwan: analysis of prescription using National Health Insurance database","volume":"84","author":"LP Hsieh","year":"2009","journal-title":"Epilepsy research"},{"issue":"8","key":"pone.0299968.ref045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1474-4422(12)70155-2","article-title":"Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional study","volume":"11","author":"CK Mbuba","year":"2012","journal-title":"The Lancet Neurology"},{"issue":"7","key":"pone.0299968.ref046","first-page":"S195","article-title":"Current challenges in the management of epilepsy","volume":"17","author":"M. Privitera","year":"2011","journal-title":"The American journal of managed care"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0299968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T18:39:57Z","timestamp":1709836797000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0299968"}},"subtitle":[],"editor":[{"given":"Tai-Heng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0299968","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]}}}